Get the Stockscreener App
11.01
0.99%
-0.11
After Hours:
11.09
0.08
+0.73%
Fibrogen Inc stock is traded at $11.01, with a volume of 15,084.
It is down -0.99% in the last 24 hours and down -6.14% over the past month.
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
See More
Previous Close:
$11.12
Open:
$11.12
24h Volume:
15,084
Relative Volume:
0.37
Market Cap:
$44.52M
Revenue:
$147.75M
Net Income/Loss:
$-284.23M
P/E Ratio:
-3.7577
EPS:
-2.93
Net Cash Flow:
$-317.54M
1W Performance:
-0.99%
1M Performance:
-6.14%
6M Performance:
+32.09%
1Y Performance:
+38.10%
1-Day Range:
$11.00
$11.27
1-Week Range:
$10.50
$11.31
52-Week Range:
$4.50
$21.94
Fibrogen Inc Stock (FGEN) Company Profile
Name
Fibrogen Inc
Sector
Industry
Phone
415-978-1200
Address
350 BAY STREET, SAN FRANCISCO, CA
Compare FGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FGEN
Fibrogen Inc
|
11.01 | 44.97M | 147.75M | -284.23M | -317.54M | -2.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-26-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-26-23 | Downgrade | Stifel | Buy → Hold |
| Jun-26-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-02-23 | Upgrade | Stifel | Hold → Buy |
| Jan-31-23 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-26-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-22-21 | Downgrade | Goldman | Neutral → Sell |
| Aug-20-21 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jul-16-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-16-21 | Downgrade | Stifel | Buy → Hold |
| Apr-07-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-07-21 | Downgrade | Mizuho | Buy → Neutral |
| Mar-31-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-02-21 | Downgrade | Jefferies | Buy → Hold |
| Feb-01-21 | Initiated | H.C. Wainwright | Buy |
| Oct-26-20 | Initiated | Raymond James | Underperform |
| Jul-10-20 | Resumed | Stifel | Buy |
| May-01-20 | Initiated | Cowen | Market Perform |
| Apr-27-20 | Initiated | BofA/Merrill | Neutral |
| May-29-19 | Resumed | Goldman | Neutral |
| May-10-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-19 | Initiated | Piper Jaffray | Neutral |
| Feb-11-19 | Resumed | Stifel | Buy |
| Dec-19-18 | Upgrade | Citigroup | Neutral → Buy |
| Aug-08-17 | Reiterated | Leerink Partners | Outperform |
| Aug-08-17 | Reiterated | Stifel | Buy |
| Jul-21-17 | Downgrade | Goldman | Buy → Neutral |
| Jul-11-17 | Initiated | Jefferies | Buy |
| Feb-11-16 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-21-16 | Initiated | Credit Suisse | Neutral |
| Dec-04-15 | Initiated | Citigroup | Buy |
| Sep-23-15 | Initiated | Lake Street | Hold |
| Jul-29-15 | Initiated | Citigroup | Buy |
| Jul-20-15 | Upgrade | Goldman | Neutral → Buy |
| Dec-09-14 | Initiated | Stifel | Buy |
View All
Fibrogen Inc Stock (FGEN) Latest News
Will earnings trigger a reversal in FibroGen Inc.2025 Winners & Losers & High Win Rate Trade Tips - newser.com
Chart based exit strategy for FibroGen Inc.Portfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Backtesting results for FibroGen Inc. trading strategies2025 Investor Takeaways & Verified Trade Idea Suggestions - newser.com
FibroGen (NASDAQ: FGEN) sets Q3 results; 5:00 PM ET conference call Monday - Stock Titan
What does recent volatility data suggest for FibroGen Inc.2025 Price Targets & Community Consensus Picks - newser.com
Should you hold or exit FibroGen Inc. nowQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Is FibroGen Inc. stock ready for a breakoutWeekly Market Report & Free High Return Stock Watch Alerts - newser.com
Building trade automation scripts for FibroGen Inc.Weekly Trend Summary & Safe Capital Investment Plans - newser.com
Is FibroGen Inc. reversing from oversold territoryTrade Volume Report & High Conviction Buy Zone Picks - newser.com
What to expect from FibroGen Inc. in the next 30 days2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com
Forecasting FibroGen Inc. price range with options dataJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
How to read the order book for FibroGen Inc.July 2025 Big Picture & Technical Pattern Recognition Alerts - newser.com
What hedge fund activity signals for FibroGen Inc. stock2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Technical signs of recovery in FibroGen Inc.July 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
Can FibroGen Inc. stock outperform in 2025 bull marketEarnings Trend Report & Reliable Entry Point Trade Alerts - newser.com
How to integrate FibroGen Inc. into portfolio analysis toolsGlobal Markets & Risk Adjusted Swing Trade Ideas - newser.com
Can FibroGen Inc. stock sustain institutional interestJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Why FibroGen Inc. stock attracts global investorsTrend Reversal & Precise Buy Zone Identification - newser.com
Can FibroGen Inc. (1FG0) stock reach $200 price target2025 Price Action Summary & Community Driven Trade Alerts - newser.com
What analysts say about FibroGen Inc 1FG0 stockShort-Term Trading Alerts & Minimal Capital Growth Plans - earlytimes.in
Is FibroGen Inc. stock attractive for hedge fundsEarnings Risk Report & AI Driven Stock Reports - newser.com
Is FibroGen Inc. (1FG0) stock expanding market penetrationAnalyst Upgrade & Reliable Intraday Trade Alerts - newser.com
Fibrogen Inc Stock (FGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):